Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.24.2.u1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
REVENUES $ 3,431 $ 1,896 $ 4,157 $ 3,744
COST OF REVENUES 1,488 1,264 1,994 2,424
GROSS PROFIT 1,943 632 2,163 1,320
OPERATING EXPENSES:        
Research and development expenses 603 669 1,250 1,426
Sales and marketing expenses, net 647 712 1,274 1,641
General and administrative expenses 790 969 1,607 1,834
Other income (163) (163)
TOTAL OPERATING EXPENSES 1,877 2,350 3,968 4,901
OPERATING PROFIT (LOSS) 66 (1,718) (1,805) (3,581)
Interest expenses (137) (171) (344) (351)
Other Financial income, net 7 296 85 444
NET COMPREHENSIVE LOSS FOR THE PERIOD $ (78) $ (1,593) $ (2,064) $ (3,488)
Net loss per share attributable to common shareholders – basic (in Dollars per share) $ (0.01) $ (0.68) $ (0.51) $ (1.72)
Weighted average number of common stocks used in computing net profit (loss) per share – basic (in Shares) 4,257,674 2,333,381 4,000,994 2,033,747